SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ARAY Accuray Cyberknife Robotic RadioSurgery
An SI Board Since October 2010
Posts SubjectMarks Bans Symbol
94 6 0 ARAY
Emcee:  Savant Type:  Moderated
Introduction Market Data Compact
About Accuray

Accuray Incorporated (ARAY), based in Sunnyvale, Calif., is a global leader in
the field of radiosurgery dedicated to providing an improved quality of life and
a non-surgical treatment option for those diagnosed with cancer. Accuray develops
and markets the CyberKnife Robotic Radiosurgery System, which extends the
benefits of radiosurgery to include extracranial tumors, including those in the
spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has
been used to treat more than 100,000 patients worldwide and more than 206 systems
have been installed in leading hospitals in the Americas, Europe and Asia. For
more information, please visit accuray.com.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
94fwiw a solid hit for me [graphic]Chartgod-10/16/2023
93Accuray Receives FDA Clearance for VitalHold(TM) on the Radixact(R) System;Savant-8/15/2023
92Accuray Incorporated to Speak at 33rd Annual Oppenheimer Healthcare ConfereSavant-3/8/2023
91Trial Data Indicates Targeted, Short Course Radiation Therapy Preserves UriSavant-2/24/2023
90Accuray Receives IMV Award for Best In Service in Radiation Oncology for 20Savant-12/1/2022
89New CEO Suzanne WinterSavant-5/2/2022
88 Accuray announced today that Royal Brisbane and Women's Hospital Savant-2/16/2022
87 Accuray announced today that data from a phase III, randomized Savant-2/10/2022
86- Phase III, randomized controlled trial results highlight patient reportedSavant-2/10/2022
85- Trigeminal neuralgia, a persistent neurological disorder, is described bySavant-12/17/2021
84Accuray Radixact® System with Synchrony® Technology Delivers Advanced Savant-9/17/2020
83Geisinger Wyoming Valley Medical Center is First in the World to Treat Patients Savant-6/17/2020
82Annual Awards Program Recognizes Outstanding Health & Medical Technology ProSavant-6/17/2020
81Please add a logo to your board.SI Ron (Colonel Sammy)-9/27/2018
80Recently Published Data Demonstrate Benefits of CyberKnife Treatment for BoSavant-9/26/2018
79 Accuray CyberKnife(R) Customer Achieves Top Score in Multiple Brain MeSavant-5/22/2018
78SUNNYVALE, Calif., April 9, 2018 /PRNewswire/ -- Accuray Incorporated (NASDSavant-4/9/2018
77Must be seeing diff techs than I do.....RSI is more toward overbought, and MACSavant-2/2/2018
76 Reports Q2 (Dec) loss of $(0.06) per share, $0.05 better than Savant-1/24/2018
75Leading Hospital will be the First in the Middle East to Offer Patients Precise Savant-7/12/2017
74- Accuray and Anova Cancer Care SUNNYVALE, Calif., June 16, 2017 /PRNewswire/ --Savant-6/22/2017
73Accuray Inc. (ARAY) filed a Form 8K - Entry Into a Definitive Agreement - with tSavant-6/21/2017
72Accuray Incorporated to Present at 2014 Jefferies Global Healthcare ConfeSavant-5/19/2014
71 Accuray Signs Three-Year Contract with AmerinetGains access tSavant-5/19/2014
70Accuray to Announce Significant Product News at ASTRO2012 ASTRO Meeting Providesrichardred-10/18/2012
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2024 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News